Company Earnings Update 3 minutesRegister for Free AccessCVS Health (CVS) 2Q17 Results: Beats Consensus, Narrows Guidance Range Coresight Research August 9, 2017 Executive Summary CVS Health reported 2Q17 adjusted EPS of $1.33, up 0.7% year over year and beating the $1.31 consensus estimate. Revenues were $45.7 billion, up 4.5% year over year, beating the $45.35 billion consensus estimate. Pharmacy Services was the fastest-growing segment, with revenues up 9.5% year over year, to $32.3 billion. Revenues in the Retail/LTC (Long-Term Care) segment declined by 2.2%. The company narrowed its 2017 adjusted EPS guidance range upward,to $5.83–$5.93 from $5.77–$5.93. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: US and China E-Commerce—Retail 2024 Sector Outlook: Online Sales To Maintain Strong Growth MomentumAnalyst Corner—Increasing Consumer-Centricity and Personalization in US Healthcare, with Swarooprani MuralidharNRF 2023: Retail’s Big Show Wrap-Up—Business Agility, Purpose, Technology and Personalization Characterize Retail’s FutureTikTok Shop: How Brands, Merchants and Creators Can Sell Products Directly on the Social Platform
